Japanese drug regulatory authorities failed to make a decision on whether favipiravir (Avigan) would be used as a treatment for […]
Scotland has kicked off a favipiravir-based study investigating the efficacy and safety of that antiviral drug targeting COVID-19 cases in […]
The eastern African nation of Rwanda appears to be joining dozens of others nations worldwide and accepting Favipiravir as a […]
Appili Therapeutics Inc. (TSX: APLI, OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious […]
A Kuwait-based clinical trial sponsored by Indian generic drug producer Dr. Reddy’s Laboratory was recently terminated as the resulting data […]
The Southeastern nation of Malaysia recently announced the planning for a major clinical trial to evaluate two low cost, widely […]
Yet another nation has opted to embrace the antiviral drug Favipiravir (Avigan) as a treatment for early onset COVID-19. Approved […]
On January 6, The Lancet’s EBIoMedicine published a commentary on the use of Favipiravir for flu and COVID-19. They note […]
With the COVID-19 pandemic conditions improving in India according to some local reports, the demand for antiviral drugs Remdesivir and […]
A growing number of articles, papers and discussions point out that despite the great news of vaccines approved for emergency […]
